<VariationArchive VariationID="1458484" VariationName="NC_000007.13:g.(?_65557534)_(65557909_?)del" VariationType="Deletion" Accession="VCV001458484" Version="6" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1468196" VariationID="1458484">
      <GeneList>
        <Gene Symbol="ASL" FullName="argininosuccinate lyase" GeneID="435" HGNC_ID="HGNC:746" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q11.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="66075819" stop="66093576" display_start="66075819" display_stop="66093576" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="65540775" stop="65558329" display_start="65540775" display_stop="65558329" Strand="+" />
          </Location>
          <OMIM>608310</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000007.13:g.(?_65557534)_(65557909_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q11.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" innerStart="65557534" innerStop="65557909" display_start="65557534" display_stop="65557909" variantLength="376" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.(?_65557534)_(65557909_?)del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.(?_65557534)_(65557909_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000007.13:g.(?_65557534)_(65557909_?)del AND Argininosuccinate lyase deficiency" Accession="RCV001956395" Version="6">
        <ClassifiedConditionList TraitSetID="605">
          <ClassifiedCondition DB="MedGen" ID="C0268547">Argininosuccinate lyase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-02-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-02-25" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="605" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="326" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Argininosuccinic Aciduria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Arginino succinase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inborn error of urea synthesis, arginino succinic type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Urea cycle disorder, arginino succinase type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Argininosuccinate lyase deficiency</ElementValue>
                <XRef ID="Argininosuccinic+Aciduria/576" DB="Genetic Alliance" />
                <XRef ID="41013004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ASL deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ASA deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Argininosuccinate acidemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Argininosuccinic acid lyase deficiency</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Deficiency of argininosuccinate lyase (ASL), the enzyme that cleaves argininosuccinic acid to produce arginine and fumarate in the fourth step of the urea cycle, may present as a severe neonatal-onset form or a late-onset form: The severe neonatal-onset form is characterized by hyperammonemia within the first few days after birth that can manifest as increasing lethargy, somnolence, refusal to feed, vomiting, tachypnea, and respiratory alkalosis. Absence of treatment leads to worsening lethargy, seizures, coma, and even death. In contrast, the manifestations of late-onset form range from episodic hyperammonemia triggered by acute infection or stress to cognitive impairment, behavioral abnormalities, and/or learning disabilities in the absence of any documented episodes of hyperammonemia. Manifestations of ASL deficiency that appear to be unrelated to the severity or duration of hyperammonemic episodes: Neurocognitive deficiencies (attention-deficit/hyperactivity disorder, developmental delay, seizures, and learning disability). Liver disease (hepatitis, cirrhosis). Trichorrhexis nodosa (coarse brittle hair that breaks easily). Systemic hypertension.</Attribute>
                <XRef ID="NBK51784" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5843" />
                <XRef ID="5843" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21290785</ID>
                <ID Source="BookShelf">NBK51784</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301396</ID>
                <ID Source="BookShelf">NBK1217</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, ACT Sheet, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Citrullinemia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, [Elevated Citrulline], Amino Acidemia/Urea Cycle Disorder, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Citrulline-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Elevated Citrulline: Amino Acidemia Algorithm, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Argininosuccinic-Acidemia-Transition.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Transition to Adult Health Care ACT Sheet, Argininosuccinic Acidemia, [Urea Cycle Disorder], 2012</CitationText>
              </Citation>
              <XRef ID="23" DB="Orphanet" />
              <XRef ID="C0268547" DB="MedGen" />
              <XRef ID="MONDO:0008815" DB="MONDO" />
              <XRef Type="MIM" ID="207900" DB="OMIM" />
              <XRef Type="primary" ID="HP:0025630" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4256527" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_000048.3_7_Deletion (exons 16-17)|MedGen:C0268547" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002243631" DateUpdated="2024-06-09" DateCreated="2022-03-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-02-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 16-17 of the ASL gene. The 5' boundary is likely confined to intron 15. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product. This variant has not been reported in the literature in individuals with ASL-related conditions. For these reasons, this variant has been classified as Pathogenic. This variant disrupts the C-terminus of the ASL protein. Other variant(s) that disrupt this region (p.Trp450*) have been determined to be pathogenic (Invitae). This suggests that variants that disrupt this region of the protein are likely to be causative of disease.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.(?_65557534)_(65557909_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268547" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4256527" TraitType="Disease" MappingType="XRef" MappingValue="C0268547" MappingRef="MedGen">
        <MedGen CUI="C0268547" Name="Argininosuccinate lyase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

